NewSquare Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-437
| Closed | -$215K | – | 249 |
|
|
2026
Q1 | $215K | Buy |
+437
| New | +$237K | 0.02% | 204 |
|
|
2025
Q3 | – | Sell |
-290
| Closed | -$118K | – | 1140 |
|
|
2025
Q2 | $118K | Buy |
290
+150
| +107% | +$62.7K | 0.01% | 204 |
|
|
2025
Q1 | $69.7K | Buy |
140
+103
| +278% | +$55.8K | 0.01% | 209 |
|
|
2024
Q4 | $19.2K | Buy |
+37
| New | +$20.3K | ﹤0.01% | 234 |
|
|
2023
Q4 | – | Sell |
-4
| Closed | -$2.02K | – | 622 |
|
|
2023
Q3 | $2.02K | Sell |
4
-2
| -33% | -$1.07K | ﹤0.01% | 456 |
|
|
2023
Q2 | $3.13K | Sell |
6
-11
| -65% | -$5.94K | ﹤0.01% | 477 |
|
|
2023
Q1 | $9.8K | Buy |
17
+11
| +183% | +$6.2K | ﹤0.01% | 352 |
|
|
2022
Q4 | $3.3K | Buy |
+6
| New | +$3.18K | ﹤0.01% | 415 |
|
|
2022
Q1 | – | Sell |
-25
| Closed | -$14.4K | – | 466 |
|
|
2021
Q4 | $17K | Hold |
25
| – | – | ﹤0.01% | 250 |
|
|
2021
Q3 | $14K | Sell |
25
-15
| -38% | -$8.23K | ﹤0.01% | 252 |
|
|
2021
Q2 | $20K | Hold |
40
| – | – | ﹤0.01% | 229 |
|
|
2021
Q1 | $18K | Hold |
40
| – | – | ﹤0.01% | 206 |
|
|
2020
Q4 | $19K | Hold |
40
| – | – | ﹤0.01% | 203 |
|
|
2020
Q3 | $18K | Hold |
40
| – | – | ﹤0.01% | 202 |
|
|
2020
Q2 | $14K | Hold |
40
| – | – | ﹤0.01% | 209 |
|
|
2020
Q1 | $11K | Sell |
40
-190
| -83% | -$59.9K | ﹤0.01% | 235 |
|
|
2019
Q4 | $75K | Buy |
230
+190
| +475% | +$57.6K | 0.01% | 154 |
|
|
2019
Q3 | $12K | Buy |
+40
| New | +$11.5K | ﹤0.01% | 189 |
|
|
2016
Q4 | – | Sell |
-158
| Closed | -$23.3K | – | 446 |
|
|
2016
Q3 | $25K | Buy |
158
+64
| +68% | +$9.86K | 0.01% | 192 |
|
|
2016
Q2 | $14K | Sell |
94
-33
| -26% | -$4.87K | ﹤0.01% | 235 |
|
|
2016
Q1 | $18K | Buy |
127
+89
| +234% | +$11.9K | 0.01% | 237 |
|
|
2015
Q4 | $5K | Buy |
38
+22
| +138% | +$2.93K | ﹤0.01% | 271 |
|
|
2015
Q3 | $2K | Hold |
16
| – | – | ﹤0.01% | 283 |
|
|
2015
Q2 | $2K | Hold |
16
| – | – | ﹤0.01% | 315 |
|
|
2015
Q1 | $2K | Hold |
16
| – | – | ﹤0.01% | 285 |
|
|
2014
Q4 | $2K | Hold |
16
| – | – | ﹤0.01% | 290 |
|
|
2014
Q3 | $2K | Hold |
16
| – | – | ﹤0.01% | 295 |
|
|
2014
Q2 | $2K | Buy |
+16
| New | +$1.88K | ﹤0.01% | 255 |
|
|
2014
Q1 | – | Sell |
-62
| Closed | -$7K | – | 262 |
|
|
2013
Q4 | $7K | Buy |
+62
| New | +$6.17K | ﹤0.01% | 207 |
|
Other funds holding TMO
NewSquare Capital's TMO Position: Q2 2026 in Review
NewSquare Capital sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 437 shares — an estimated $215K sold.
NewSquare Capital first reported a position in TMO in Q4 2013 and held it in 29 quarters. The position peaked at $215K in Q1 2026. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- NewSquare Capital reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
- NewSquare Capital sold 437 Thermo Fisher Scientific shares in Q2 2026, an estimated $215K.
- NewSquare Capital first reported a position in Thermo Fisher Scientific in Q4 2013 and held it in 29 quarters.
- NewSquare Capital's Thermo Fisher Scientific position peaked at $215K in Q1 2026.
- 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on NewSquare Capital's 13F filing for Q2 2026, filed 28 Jul 2026.